| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myHome |
| Orderbuch | Realtime Stuttgart | RSS Feed | Analyse | im Forum | Fonds | Senden |
| Historisch | Realtime Push | myNews neu | IR-Daten | Anleihen | handeln | |
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Barclays Capital | 36,00$ | +8,01% | 30.04.12 | |||
| Citigroup Corp. | 40,00$ | +20,01% | 08.11.11 | |||
| UBS AG | 30,00$ | -9,99% | 27.10.11 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Bayer | 15 | 12 | 0 | 61,22 € | +25,40% |
| Bristol-Myers Squibb Co. | 2 | 1 | 0 | 35,33 $ | +6,00% |
| Celgene Corp. | 8 | 1 | 0 | 82,71 $ | +26,60% |
| GlaxoSmithKline plc (GSK) | 5 | 8 | 1 | 15,31 £ | +8,20% |
| Merck Co. | 2 | 3 | 0 | 38,50 $ | +3,55% |
| Merck KGaA | 4 | 17 | 1 | 81,56 € | +9,80% |
| Novartis AG | 10 | 8 | 1 | 56,60 | +13,27% |
| Pfizer Inc. | 7 | 4 | 1 | 23,75 $ | +9,75% |
| Sanofi S.A. | 13 | 8 | 2 | 58,61 € | +9,53% |